A citation-based method for searching scientific literature

Elvira D'Andrea, Carolina Marzuillo, Corrado De Vito, Marco Di Marco, Erica Pitini, Maria Rosaria Vacchio, Paolo Villari. Genet Med 2016
Times Cited: 41







List of co-cited articles
197 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
17

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
17

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
96
17

How is genetic testing evaluated? A systematic review of the literature.
Erica Pitini, Corrado De Vito, Carolina Marzuillo, Elvira D'Andrea, Annalisa Rosso, Antonio Federici, Emilio Di Maria, Paolo Villari. Eur J Hum Genet 2018
29
20

Genetic testing and economic evaluations: a systematic review of the literature.
Elvira D'Andrea, Carolina Marzuillo, Ferruccio Pelone, Corrado De Vito, Paolo Villari. Epidemiol Prev 2015
16
37

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
12

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
12

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
30
16

Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Janice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, Charlotte C Sun, Molly S Daniels, Karen H Lu, Banu Arun. J Clin Oncol 2010
99
12

Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
Marco Di Marco, Elvira DAndrea, Nikola Panic, Valentina Baccolini, Giuseppe Migliara, Carolina Marzuillo, Corrado De Vito, Roberta Pastorino, Stefania Boccia, Paolo Villari. Genet Med 2018
25
20

Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia.
Elvira D'Andrea, Tyra Lagerberg, Corrado De Vito, Erica Pitini, Carolina Marzuillo, Azzurra Massimi, Maria Rosaria Vacchio, Paola Grammatico, Paolo Villari. Eur J Hum Genet 2018
8
62

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
9


Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Kelly A Metcalfe, Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun, Steven A Narod. J Clin Oncol 2010
109
9

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
9

Cost-effectiveness of testing for breast cancer susceptibility genes.
Margaret L Holland, Alissa Huston, Katia Noyes. Value Health 2009
31
12


Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy.
Carolina Marzuillo, Corrado De Vito, Maddalena D'Addario, Paola Santini, Elvira D'Andrea, Antonio Boccia, Paolo Villari. BMC Health Serv Res 2014
12
33

What is the clinical utility of genetic testing?
Scott D Grosse, Muin J Khoury. Genet Med 2006
171
9

Personal utility in genomic testing: a systematic literature review.
Jennefer N Kohler, Erin Turbitt, Barbara B Biesecker. Eur J Hum Genet 2017
48
9

Predictive genetic testing for complex diseases: a public health perspective.
C Marzuillo, C De Vito, E D'Andrea, A Rosso, P Villari. QJM 2014
12
33

The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
A Rosso, E Pitini, E D'Andrea, A Massimi, C De Vito, C Marzuillo, P Villari. Ann Ig 2017
11
36

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
Reshma Jagsi, Kent A Griffith, Allison W Kurian, Monica Morrow, Ann S Hamilton, John J Graff, Steven J Katz, Sarah T Hawley. J Clin Oncol 2015
59
7


Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
61
7

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
7

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
7

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
7

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Laura J Havrilesky, Gloria Broadwater, Debra M Davis, Kimberly C Nolte, J Cory Barnett, Evan R Myers, Shalini Kulasingam. Gynecol Oncol 2009
78
7

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
7

Health-state utility values in breast cancer.
Tessa Peasgood, Sue E Ward, John Brazier. Expert Rev Pharmacoecon Outcomes Res 2010
82
7

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
144
7

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?
Matthew B Yurgelun, Elaine Hiller, Judy E Garber. J Clin Oncol 2015
36
8

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
665
7


Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
799
7


Current priorities for public health practice in addressing the role of human genomics in improving population health.
Muin J Khoury, Michael S Bowen, Wylie Burke, Ralph J Coates, Nicole F Dowling, James P Evans, Michele Reyes, Jeannette St Pierre. Am J Prev Med 2011
51
7

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Steven M Teutsch, Linda A Bradley, Glenn E Palomaki, James E Haddow, Margaret Piper, Ned Calonge, W David Dotson, Michael P Douglas, Alfred O Berg. Genet Med 2009
463
7

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.
W D Dotson, M P Douglas, K Kolor, A C Stewart, M S Bowen, M Gwinn, A Wulf, H M Anders, C Q Chang, M Clyne,[...]. Clin Pharmacol Ther 2014
40
7

A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification.
Alessia Tognetto, Maria Benedetta Michelazzo, Giovanna Elisa Calabró, Brigid Unim, Marco Di Marco, Walter Ricciardi, Roberta Pastorino, Stefania Boccia.  2017
8
37


Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
Janice S Kwon, Molly S Daniels, Charlotte C Sun, Karen H Lu. J Clin Oncol 2010
48
7

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
Kandice K Ludwig, Joan Neuner, Annabelle Butler, Jennifer L Geurts, Amanda L Kong. Am J Surg 2016
77
7

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
7

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
7

Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer.
Carolina Marzuillo, Corrado De Vito, Stefania Boccia, Maddalena D'Addario, Elvira D'Andrea, Paola Santini, Antonio Boccia, Paolo Villari. Prev Med 2013
35
8

Current state of genomic policies in healthcare among EU member states: results of a survey of chief medical officers.
W Mazzucco, R Pastorino, T Lagerberg, M Colotto, E d'Andrea, C Marotta, C Marzuillo, P Villari, A Federici, W Ricciardi,[...]. Eur J Public Health 2017
11
27

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
69
7

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
50
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.